instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lens extraction'. | Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
This study compared the outcomes of cataract surgery with intraocular lens (IOL) implantation in patients with juvenile idiopathic arthritis (JIA)-associated chronic anteri... | ADALIMUMAB, AZATHIOPRINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34072679 | 20,561,706 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Macular oedema'. | Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
This study compared the outcomes of cataract surgery with intraocular lens (IOL) implantation in patients with juvenile idiopathic arthritis (JIA)-associated chronic anteri... | ADALIMUMAB, AZATHIOPRINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34072679 | 20,561,706 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ocular hypertension'. | Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
This study compared the outcomes of cataract surgery with intraocular lens (IOL) implantation in patients with juvenile idiopathic arthritis (JIA)-associated chronic anteri... | ADALIMUMAB, AZATHIOPRINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34072679 | 20,561,706 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Retinal detachment'. | Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
This study compared the outcomes of cataract surgery with intraocular lens (IOL) implantation in patients with juvenile idiopathic arthritis (JIA)-associated chronic anteri... | ADALIMUMAB, AZATHIOPRINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34072679 | 20,561,706 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fanconi syndrome acquired'. | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | CALCIUM CARBONATE, EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL FUMARATE, VITAMIN D NOS | DrugsGivenReaction | CC BY | 34073672 | 19,397,399 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fanconi syndrome'. | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | CALCIUM CARBONATE, EMTRICITABINE, TENOFOVIR, VITAMIN D NOS | DrugsGivenReaction | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foot fracture'. | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | CALCIUM CARBONATE, EMTRICITABINE, TENOFOVIR, VITAMIN D NOS | DrugsGivenReaction | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal tubular acidosis'. | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | CALCIUM CARBONATE, EMTRICITABINE, TENOFOVIR, VITAMIN D NOS | DrugsGivenReaction | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
What was the dosage of drug 'CALCIUM CARBONATE'? | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | 600 MILLIGRAM, QD | DrugDosageText | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
What was the dosage of drug 'TENOFOVIR'? | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | UNK, FROM 10 YEARS | DrugDosageText | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
What was the dosage of drug 'VITAMIN D NOS'? | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | 400 INTERNATIONAL UNIT, QD | DrugDosageText | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
What was the outcome of reaction 'Fanconi syndrome acquired'? | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | Recovered | ReactionOutcome | CC BY | 34073672 | 19,397,399 | 2021-05-24 |
What was the outcome of reaction 'Fanconi syndrome'? | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | Recovered | ReactionOutcome | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
What was the outcome of reaction 'Foot fracture'? | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | Recovered | ReactionOutcome | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
What was the outcome of reaction 'Hypophosphataemic osteomalacia'? | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | Recovered | ReactionOutcome | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
What was the outcome of reaction 'Renal tubular acidosis'? | Fanconi Syndrome Leading to Hypophosphatemic Osteomalacia Related to Tenofovir Use.
Tenofovir disoproxil fumarate (TDF) is used worldwide to treat and prevent Human Immunodeficiency Virus (HIV) infection. Fanconi syndrome is a complication of TDF use and is characterized by inadequate reabsorption of glucose, phosphate... | Recovered | ReactionOutcome | CC BY | 34073672 | 19,499,808 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blindness transient'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blindness unilateral'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blindness'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Corneal oedema'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diplopia'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exophthalmos'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye haemorrhage'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,133,290 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye movement disorder'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye oedema'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye pain'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Eye swelling'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fall'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematoma'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intraocular haematoma'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,142,379 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intraocular pressure test'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mass'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Optic nerve cupping'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Orbital compartment syndrome'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Periorbital haematoma'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Periorbital haemorrhage'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Periorbital oedema'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pupillary reflex impaired'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Soft tissue swelling'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stress'. | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | APIXABAN, CLOPIDOGREL BISULFATE, HEPARIN SODIUM | DrugsGivenReaction | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
What was the outcome of reaction 'Blindness unilateral'? | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | Not recovered | ReactionOutcome | CC BY | 34073719 | 20,142,379 | 2021-05-24 |
What was the outcome of reaction 'Blindness'? | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | Not recovered | ReactionOutcome | CC BY | 34073719 | 20,226,448 | 2021-05-24 |
What was the outcome of reaction 'Headache'? | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | Not recovered | ReactionOutcome | CC BY | 34073719 | 20,219,394 | 2021-05-24 |
What was the outcome of reaction 'Intraocular haematoma'? | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | Not recovered | ReactionOutcome | CC BY | 34073719 | 20,142,379 | 2021-05-24 |
What was the outcome of reaction 'Ocular retrobulbar haemorrhage'? | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | Not recovered | ReactionOutcome | CC BY | 34073719 | 20,092,319 | 2021-05-24 |
What was the outcome of reaction 'Orbital compartment syndrome'? | Doubly Blinded: An Uncommon Cause of Acute Visual Loss Due to Orbital Compartment Syndrome.
A 68-year-old female patient with a past medical history of atrial fibrillation on anticoagulation regimen with Apixaban and Clopidogrel presented for her scheduled Watchman device implantation. The device was indicated as patie... | Not recovered | ReactionOutcome | CC BY | 34073719 | 20,092,319 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bladder spasm'. | Mycobacterium Avium Complex Genitourinary Infections: Case Report and Literature Review.
Nontuberculous mycobacterial (NTM) genitourinary (GU) infections are relatively rare, and there is frequently a delay in diagnosis. Mycobacterium avium-intracellulare complex (MAC) cases seem to be less frequent than other NTM as a... | CLARITHROMYCIN, ETHAMBUTOL HYDROCHLORIDE, RIFAMPIN, SILVER NITRATE | DrugsGivenReaction | CC BY | 34073729 | 19,877,696 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Mycobacterium Avium Complex Genitourinary Infections: Case Report and Literature Review.
Nontuberculous mycobacterial (NTM) genitourinary (GU) infections are relatively rare, and there is frequently a delay in diagnosis. Mycobacterium avium-intracellulare complex (MAC) cases seem to be less frequent than other NTM as a... | CLARITHROMYCIN, ETHAMBUTOL HYDROCHLORIDE, RIFAMPIN, SILVER NITRATE | DrugsGivenReaction | CC BY | 34073729 | 19,877,696 | 2021-05-24 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Mycobacterium Avium Complex Genitourinary Infections: Case Report and Literature Review.
Nontuberculous mycobacterial (NTM) genitourinary (GU) infections are relatively rare, and there is frequently a delay in diagnosis. Mycobacterium avium-intracellulare complex (MAC) cases seem to be less frequent than other NTM as a... | CLARITHROMYCIN, ETHAMBUTOL HYDROCHLORIDE, RIFAMPIN, SILVER NITRATE | DrugsGivenReaction | CC BY | 34073729 | 19,877,696 | 2021-05-24 |
What was the administration route of drug 'CLARITHROMYCIN'? | Mycobacterium Avium Complex Genitourinary Infections: Case Report and Literature Review.
Nontuberculous mycobacterial (NTM) genitourinary (GU) infections are relatively rare, and there is frequently a delay in diagnosis. Mycobacterium avium-intracellulare complex (MAC) cases seem to be less frequent than other NTM as a... | Oral | DrugAdministrationRoute | CC BY | 34073729 | 19,877,696 | 2021-05-24 |
What was the administration route of drug 'ETHAMBUTOL HYDROCHLORIDE'? | Mycobacterium Avium Complex Genitourinary Infections: Case Report and Literature Review.
Nontuberculous mycobacterial (NTM) genitourinary (GU) infections are relatively rare, and there is frequently a delay in diagnosis. Mycobacterium avium-intracellulare complex (MAC) cases seem to be less frequent than other NTM as a... | Oral | DrugAdministrationRoute | CC BY | 34073729 | 19,877,696 | 2021-05-24 |
What was the administration route of drug 'RIFAMPIN'? | Mycobacterium Avium Complex Genitourinary Infections: Case Report and Literature Review.
Nontuberculous mycobacterial (NTM) genitourinary (GU) infections are relatively rare, and there is frequently a delay in diagnosis. Mycobacterium avium-intracellulare complex (MAC) cases seem to be less frequent than other NTM as a... | Oral | DrugAdministrationRoute | CC BY | 34073729 | 19,877,696 | 2021-05-24 |
What was the administration route of drug 'SILVER NITRATE'? | Mycobacterium Avium Complex Genitourinary Infections: Case Report and Literature Review.
Nontuberculous mycobacterial (NTM) genitourinary (GU) infections are relatively rare, and there is frequently a delay in diagnosis. Mycobacterium avium-intracellulare complex (MAC) cases seem to be less frequent than other NTM as a... | Other | DrugAdministrationRoute | CC BY | 34073729 | 19,877,696 | 2021-05-24 |
What was the dosage of drug 'SILVER NITRATE'? | Mycobacterium Avium Complex Genitourinary Infections: Case Report and Literature Review.
Nontuberculous mycobacterial (NTM) genitourinary (GU) infections are relatively rare, and there is frequently a delay in diagnosis. Mycobacterium avium-intracellulare complex (MAC) cases seem to be less frequent than other NTM as a... | INSTILLATION ROUTE | DrugDosageText | CC BY | 34073729 | 19,877,696 | 2021-05-24 |
What was the dosage of drug 'PANTOPRAZOLE SODIUM'? | Symptomatic Hypoglycemia During Treatment with a Therapeutic Dose of Metformin.
BACKGROUND Metformin has a longstanding reputation as the first-line treatment for glycemic control in the setting of diabetes mellitus type 2. A contributing factor to this reputation is metformin having a low risk of inducing hypoglycemia... | 40 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34075013 | 19,453,816 | 2021-06-02 |
What was the outcome of reaction 'Hypoglycaemia'? | Symptomatic Hypoglycemia During Treatment with a Therapeutic Dose of Metformin.
BACKGROUND Metformin has a longstanding reputation as the first-line treatment for glycemic control in the setting of diabetes mellitus type 2. A contributing factor to this reputation is metformin having a low risk of inducing hypoglycemia... | Recovered | ReactionOutcome | CC BY-NC-ND | 34075013 | 20,203,708 | 2021-06-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Intra cardiac thrombus in critically ill patient with coronavirus disease 2019: Case report.
With the outbreak of COVID-19, the number of cardiac manifestations related to this virus was more remarquable, among them heart thrombus (HTh) which is considered as a rare and severe complication associated with thromboemboli... | ALTEPLASE, DEXAMETHASONE, DOBUTAMINE HYDROCHLORIDE, HEPARIN SODIUM, NOREPINEPHRINE | DrugsGivenReaction | CC BY-NC-ND | 34075321 | 19,717,642 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Intra cardiac thrombus in critically ill patient with coronavirus disease 2019: Case report.
With the outbreak of COVID-19, the number of cardiac manifestations related to this virus was more remarquable, among them heart thrombus (HTh) which is considered as a rare and severe complication associated with thromboemboli... | ALTEPLASE, DEXAMETHASONE, DOBUTAMINE HYDROCHLORIDE, HEPARIN SODIUM, NOREPINEPHRINE | DrugsGivenReaction | CC BY-NC-ND | 34075321 | 19,717,642 | 2021-06 |
What was the dosage of drug 'ALTEPLASE'? | Intra cardiac thrombus in critically ill patient with coronavirus disease 2019: Case report.
With the outbreak of COVID-19, the number of cardiac manifestations related to this virus was more remarquable, among them heart thrombus (HTh) which is considered as a rare and severe complication associated with thromboemboli... | 100 MILLIGRAM, Q2H | DrugDosageText | CC BY-NC-ND | 34075321 | 19,717,642 | 2021-06 |
What was the dosage of drug 'DEXAMETHASONE'? | Intra cardiac thrombus in critically ill patient with coronavirus disease 2019: Case report.
With the outbreak of COVID-19, the number of cardiac manifestations related to this virus was more remarquable, among them heart thrombus (HTh) which is considered as a rare and severe complication associated with thromboemboli... | 6 MILLIGRAM, QD | DrugDosageText | CC BY-NC-ND | 34075321 | 19,717,642 | 2021-06 |
What was the dosage of drug 'DOBUTAMINE HYDROCHLORIDE'? | Intra cardiac thrombus in critically ill patient with coronavirus disease 2019: Case report.
With the outbreak of COVID-19, the number of cardiac manifestations related to this virus was more remarquable, among them heart thrombus (HTh) which is considered as a rare and severe complication associated with thromboemboli... | 2 MICROGRAM/KILOGRAM, QMINUTE | DrugDosageText | CC BY-NC-ND | 34075321 | 19,717,642 | 2021-06 |
What was the dosage of drug 'NOREPINEPHRINE'? | Intra cardiac thrombus in critically ill patient with coronavirus disease 2019: Case report.
With the outbreak of COVID-19, the number of cardiac manifestations related to this virus was more remarquable, among them heart thrombus (HTh) which is considered as a rare and severe complication associated with thromboemboli... | 0.05 MICROGRAM/KILOGRAM, QMINUTE | DrugDosageText | CC BY-NC-ND | 34075321 | 19,717,642 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bladder discomfort'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dry skin'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fibrous dysplasia of bone'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Flatulence'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperaesthesia teeth'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypercalcaemia'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperparathyroidism'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Musculoskeletal stiffness'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myalgia'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Onychoclasis'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oral mucosal blistering'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis of jaw'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory tract infection'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vertigo'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | ACETAMINOPHEN, DENOSUMAB | DrugsGivenReaction | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
What was the administration route of drug 'DENOSUMAB'? | Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
Denosumab (Dmab) treatment can benefit patients with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by suppressing the receptor activator of nuclear factor κB ligand (RANKL)-mediated incr... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34076303 | 19,411,000 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT).
This post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) examined the performance of chlorthalidone (C) versus amlodipine (A) monotherapies. ANOVA was used to analyze the differen... | AMLODIPINE BESYLATE, CHLORTHALIDONE | DrugsGivenReaction | CC BY-NC-ND | 34076333 | 19,484,719 | 2021-07 |
What was the dosage of drug 'AMLODIPINE BESYLATE'? | Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT).
This post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) examined the performance of chlorthalidone (C) versus amlodipine (A) monotherapies. ANOVA was used to analyze the differen... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34076333 | 19,484,719 | 2021-07 |
What was the dosage of drug 'CHLORTHALIDONE'? | Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT).
This post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) examined the performance of chlorthalidone (C) versus amlodipine (A) monotherapies. ANOVA was used to analyze the differen... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 34076333 | 19,484,719 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial fibrillation'. | Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma associated with a monoclonal immunoglobulin M protein. Extranodal involvement in WM is not very common. In this article, we pre... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34078157 | 19,420,931 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood immunoglobulin M increased'. | Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma associated with a monoclonal immunoglobulin M protein. Extranodal involvement in WM is not very common. In this article, we pre... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34078157 | 19,420,931 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma associated with a monoclonal immunoglobulin M protein. Extranodal involvement in WM is not very common. In this article, we pre... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34078157 | 19,420,931 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effect less than expected'. | Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma associated with a monoclonal immunoglobulin M protein. Extranodal involvement in WM is not very common. In this article, we pre... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34078157 | 19,420,931 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dysarthria'. | Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma associated with a monoclonal immunoglobulin M protein. Extranodal involvement in WM is not very common. In this article, we pre... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34078157 | 19,420,931 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Facial paresis'. | Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma associated with a monoclonal immunoglobulin M protein. Extranodal involvement in WM is not very common. In this article, we pre... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34078157 | 19,420,931 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscular weakness'. | Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma associated with a monoclonal immunoglobulin M protein. Extranodal involvement in WM is not very common. In this article, we pre... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34078157 | 19,420,931 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Waldenstrom Macroglobulinemia Manifesting as Acute Kidney Injury and Bing-Neel Syndrome With Excellent Response to Ibrutinib.
Waldenstrom macroglobulinemia (WM) is a lymphoplasmacytic lymphoma associated with a monoclonal immunoglobulin M protein. Extranodal involvement in WM is not very common. In this article, we pre... | CYCLOPHOSPHAMIDE, DEXAMETHASONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 34078157 | 19,420,931 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.